Dorsey Brian 4
4 · ARS Pharmaceuticals, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Dorsey Brian
Chief Operating Officer
Transactions
- Award
Stock option (right to buy)
2024-01-02+350,000→ 350,000 totalExercise: $5.58Exp: 2034-01-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.